Vertex has recorded some 25,000 prescriptions for Journavx since its January approval and is in the process of getting big ...

We recently published a list of 11 Best Performing Large Cap Stocks So Far in 2025. In this article, we are going to take a ...

CVS Health Corp, a vertically integrated healthcare conglomerate, is headquartered in Woonsocket, Rhode Island. The company's ...

A fairly common scene from childhood— my mother furiously rocking in her chair, the phone cord stretched to its limit, grinding a hole into the floral wallpaper as she sparred with some health ...

CVS Health Corp. reported a strong start to 2025, with first-quarter revenue climbing 7%, driven by growth across all ...

CVS Caremark has selected Novo Nordisk’s Wegovy as the preferred GLP-1 medication for its largest commercial template formularies, effective July 1. In March, Novo Nordisk launched NovoCare Pharmacy ...

CVS Health Corp.’s drug-benefits unit negotiated a deal to make Novo Nordisk A/S’s Wegovy more widely available to its ...

Starting July 1, Wegovy will become the preferred GLP-1 for obesity treatment on CVS Caremark’s largest commercial template ...

Wegovy to become preferred GLP-1 drug on CVS Caremark's top formularies in 2025 as Novo Nordisk expands patient access ...

Eli Lilly and Company's stock dropped 11% after CVS's Zepbound exclusion, but analysts see a mispricing opportunity. Click ...

CVS said it will expand access to blockbuster weight loss drug Wegovy for patients covered by its pharmacy benefit manager, Caremark.